dr benjamin garfield brompton hospital

Efficacy of domiciliary non-invasive ventilation in patients with respiratory failure due to non-CF bronchiectasis, Study contact information Name:Dr Johanna FearyEmail:J.Feary@rbht.nhs.uk, Study Coronary sinus reducer Objective impact on Symptoms, MRI Ischaemia and microvascular Resistance, Study contact informationName: Dr Ranil De SilvaEmail: r.desilva2@rbht.nhs.uk. Study contact informationName:Paula RogersEmail:p.rogers@rbht.nhs.uk, Study First In Human Clinical Investigation of the FIRE1 System in Heart Failure Patients, Study contact information Physician and teacher Benjamin Golding was dedicated to providing free medical treatment to the poor. A Phase 3, Randomized, Double-Blind, PlaceboControlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) World Health Organization (WHO) Functional Class (FC) III or FC IV at High Risk of Mortality. Prevention of post-operative complications by using HMG-CoA reductase inhibitor in patients undergoing oesophagectomy. Name:Dr SaeedMirsadraeeEmail:S.Mirsadraee@rbht.nhs.uk, Principal investigator Name:Deirdre FlanneryEmail:D.Flannery@rbht.nhs.uk, Study Study contact information Though 20% of people with COPD have never smoked and not all smokers develop COPD - it is mainly caused by smoking from early adulthood. See photos, tips, similar places specials, and more at Cils et ongles onglerie voiron C&O Lifestyle and exercise in Hypertrophic Cardiomyopathy, Study Studying endothelial senescence and dysfunction in chronic lung disease, Study contact information Non-invasive detection of Pseudomonas aeruginosa lower airway infection in patients with Cystic Fibrosis, Study contact information Study contact information Study contact information Name: DrSaeedAlghamdiEmail:S.Alghamdi@rbht.nhs.uk. Reliability and validity of impulse oscillometry measurements in idiopathic pulmonary fibrosis, Study Genetics of susceptibility and mortality in critical care, Study contact informationName:Natalie Dormand (Royal Brompton), Paula Rogers (Harefield)Email:N.Dormand@rbht.nhs.uk, p.rogers@rbht.nhs.uk, Study Study Name: Dr Haseeb ValliEmail: h.valli@rbht.nhs.uk, Study Dr.Penisson Laurence . Study Name:Maria MartinsEmail:M.Martins@rbht.nhs.uk, Principal investigator Study Name:Sarah JonesEmail:S.Jones5@rbht.nhs.uk, Study Multicentre, open-label, active-controlled, randomised study to evaluate the efficacy and safety of an age and body weight-adjusted rivaroxaban regimen in children with acute venous thromboembolism, Study contact information COPD is a life-long condition that makes breathing difficult because the airways have been narrowed. Studying the airway microenvironment in patients undergoing surgical and bronchoscopic interventions for COPD, Study Pre-school Wheeze: Predicting Progression to School Aged Asthma, Study contact information Professor Eric Alton, Study contact information Dr Philip Molyneaux, Study Name:Dr Brijesh PatelEmail:B.Patel4@rbht.nhs.uk. A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety and Tolerability, and Pharmacokinetics of INS1007 Administered Once Daily for 24 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis, Study Study Professor Susanna Price & Dr Vasileios Panoulas, Study Mr Philip Molyneaux, Study Study Name: Kyle McBeathEmail: K.McBeath@rbht.nhs.uk, Study The HarEfield Acute MyocaRdial InfarcTion Cohort, Study contact informationName:Laura BarkerEmail:L.Barker2@rbht.nhs.uk, Study As well as developing new treatments and procedures, they teach, lecture and publish articles around the world. Study contact informationName: Sally MeahEmail:sally.meah@imperial.ac.uk, Study TrIFIC: Targeting Immunotherapy for Fungal Infection in Cystic Fibrosis, Study contact information Can thrombosis and fibrinolysis markers in patients undergoing aortic valve replacement predict outcome, Study contact information The Feasibility of Continuous Bronchoscopy During Exercise in Healthy Adults in Assessing Large Airways Collapse, Study contact informationName: Alexandros MitropoulosEmail:A.Mitropoulos@rbht.nhs.uk, Study 3 Adult Intensive Care Unit, Harefield Hospital, Harefield, UK. Study This provider currently accepts 50 insurance plans including Medicare and Medicaid. Study contact information Study contact information Epidemiological trends and outcomes of hospital admissions for acute myocarditis and dilated cardiomyopathy in the National Health Service of England from 1998 onwards. Name:Brian HallidayEmail:B.Halliday@rbht.nhs.uk, Study Areas of Expertise. A subject and investigator blinded, randomized, placebo-controlled, repeat-dose, multicenter study to investigate efficacy, safety, and tolerability of CMK389 in patients with chronic pulmonary sarcoidosis, Study Name: Dr Anand ShahEmail:A.Shah2@rbht.nhs.uk, Study The O-COPD trial: Oscillatory Positive Expiratory Pressure (OPEP) devices to improve outcome in patients with Chronic Obstructive Pulmonary Disease (COPD), Study contact information Name:Dr Christoph NienaberEmail:C.Nienaber@rbht.nhs.uk, Principal investigator Targets of bronchial thermoplasty in severe asthma, Study contact information Dr Vasilis Kouranos, Study Royal Brompton Hospital is a regional centre for pulmonary hypertension in the UK. Study Study contact information Name:Louise SelbyEmail:L.Selby@rbht.nhs.uk, Study Name: Dr Duncan MacraeEmail: D.Macrae@rbht.nhs.uk, Study Name:Sandra ScottEmail:s.scott@rbht.nhs.uk. A Multi-Cohort, Randomized, Placebo-Controlled Phase 2a Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Ascending Doses of RXC007 in Patients with Idiopathic Pulmonary Fibrosis. Professor John Pepper, Study RePneu lung volume reduction coil - European Registry. Name:Avantika TailorEmail:A.Tailor@rbht.nhs.uk, Study Name:Dr Claire HoggEmail:c.hogg@rbht.nhs.uk, Study A randomised pragmatic trial of corticosteroid optimisation in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care, Study contact information Name:Dr DeepaArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk, Principal investigator Background: The risk of complications, including death, is substantially increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, especially in those with pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH). An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH, Study Long--term Outcomes in Long Standing Persistent Atrial Fibrillation Following Catheter Or Thoracoscopic Surgical Ablation : Extended Follow-Up Of CASA-AF Randomised Controlled Trial, Study contact information Name: Lisa BrightonEmail:L.Brighton@rbht.nhs.uk, Study Fingerprinting proteoglycan turnover by ADAMTS proteases in the cardiovasculature, Study contact information Identifying predictors for maintenance of exercise participation in children and young people with cystic fibrosis. Coagulopathy associated with COVID 19 (CA-COVID19) A Multi-Centre observational study in UK, Study contact information Name:Najwa SoussiEmail: n.soussi@rbht.nhs.uk, Principal investigator Name: David SmithEmail: d.smith22@rbht.nhs.uk, Study Study contact information Name:Mr Andreas HoschtitzkyEmail:A.Hoschtitzky@rbht.nhs.uk, Principal investigator Prevalence of Pompes disease amongst patients with unexplained respiratory muscle weakness or respiratory failure, Study contact information A Basic Science Study of Optimised Temporary Pacing in Patients following Cardiac Surgery in Order to Build a Pacing Simulator and Automatic Alerting Algorithm. Name: Clare SaundersEmail:C.Saunders2@rbht.nhs.uk. Study contact informationName: Dr Matthew O'ConnorEmail: Principal investigator Name:Dr GiuliaCrapelliEmail:G.Crapelli@rbht.nhs.uk, Principal investigator Study contact informationName: Dr Richard JonesEmail:r.jones@rbht.nhs.uk, Study Improving Primary Ciliary Dyskinesia diagnosis using artificial intelligence, Study contact information Multicenter, open-label, single dose study to evaluate the safety, tolerability and pharmacokinetics of LCZ696 followed by randomised, double-blind, parallel group,active-controlled study to evaluate the efficacy and safety of LCZ696 in pediatric patients, Study contact information Find All Providers . A multicentre, randomised, double blind, placebo controlled trial (Prevention HARP 2), Study Name: Dr Andres Rico-ArmadaEmail: a.rico-armada@rbht.nhs.uk, Principal investigator Name: Dr Nicholas HopkinsonEmail: n.hopkinson@rbht.nhs.uk, Principal investigator Name:Sarah CollinsEmail:s.collins@rbht.nhs.uk, Study Study contact informationName: Jovile KazileviciuteEmail: j.kazileviciute@rbht.nhs.uk, Study Study Professor David Firmin, Study Catheter versus thoracoscopic surgical ablation in long standing persistent Atrial Fibrillation - multicentre randomised control trial, Study Investigating management of lung nodules, and the impact of pre-diagnostic surveillance on health and economic outcomes, Study Name:Paolo ParediEmail:P.Paredi@rbht.nhs.uk. Name: Heather ProbertEmail: H.Probert@rbht.nhs.uk, Study Name: Antonio BarberaEmail: a.barbera@rbht.nhs.uk, Study Dr Samantha Irving, Study A Phase 3, Randomized, Double-blind, Placebo-controlled study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate-and High-risk PAH Patients. Name:Matt PavittEmail:M.Pavitt@rbht.nhs.uk, Principal investigator Study contact informationName: Abigail WatsonEmail: a.watson2@rbht.nhs.uk. Lung nodule Imaging Biobank for Radiomics and AI research (LIBRA), Study contact information Dr Rodney Franklin, Study The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): a randomised placebo-controlled multi-centre clinical trial, Study A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of BG00011 in patients with Idiopathic Pulmonary Fibrosis. Dr James Darius-Armstrong, Study Utility of cardiopulmonary exercise testing and stress echocardiography in the assessment of breathlessness following pulmonary embolism: a pilot study, Study Name: Dr Ley Taing ChanEmail: l.chan3@rbht.nhs.uk, Study Impact of premature birth on the gastrointestinal microbiota in early infancy and respiratory health at school age: a comparison of premature and term birth cohorts. Name: Dr Brian HallidayEmail: B.Halliday@rbht.nhs.uk, Study Study Name:Dr Philip MolyneauxEmail:P.Molyneaux@rbht.nhs.uk. Study EURO SHOCK Testing the value of novel strategy and its cost efficacy in order to improve the poor outcomes in Cardiogenic Shock. Treating severe paediatric asthma; a randomised controlled trial of mepolizumab and omalizumab (TREAT trial), Study contact information Iron and Chronic Obstructive Pulmonary Disease (COPD) exercise trial, Study contact information The Effects of inorganic nitrite on cardiac and skeletal muscle: Physiology, pharmacology, and therapeutic potential in patients with Chronic Heart Failure, Study contact information Study Evaluating Outpatient Video Consultations in Heart Failure: Clinician and Patient Perspectives. An international patient-led registry in fibrotic interstitial lung diseases using eHealth technology. Dr Mario Petrou & Dr Sunil Bhudia, Study Study AI & radiomics for Stratification Of lung Nodules After Radically treated cancer, Study contact information Name:Neil WestEmail:N.West@rbht.nhs.uk. Professor Sanjay Prasad, Study Project Fizzyo: Remote monitoring and gaming technology for improving physiotherapy prescription, adherence and prediction of clinical outcomes in children with cystic fibrosis. A multicenter, open-label, 8 day treatment study to assess the pharmacokinetics, safety and tolerability of fevipiprant delivered via a once daily chewable tablet in children aged 6 to <12 years with asthma. A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF). Name: Ashraf HussainEmail: a.hussain@rbht.nhs.uk, Study Study The London COPD cohort respiratory syncytial virus (RSV) study, Study contact information Study contact informationName: Lyn PaulEmail: l.paul@rbht.nhs.uk, Study Study contact information Non-ST-segment elevation myocardial infarction Registry. Royal Brompton and Harefield hospitals are home to seven purpose-built catheter laboratories, where each year our consultants carry out over 400 coronary angioplasties (stenting) to help widen arteries. Name:Ms Rebecca LaneEmail:r.lane@rbht.nhs.uk, Study The Effect of Air Pollution on Small Airway Lung Function in COPD. ROR-PH-303 - A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION, Study Name:Professor Michael LoebingerEmail:M.Loebinger@rbht.nhs.uk. Name:Gemma StanfordEmail:G.Stanford@rbht.nhs.uk, Principal investigator Name:Dr Louise FlemingEmail:L.Fleming@rbht.nhs.uk. Utilising novel dipole density capabilities to objectively visualize the etiology of recurrent atrial fibrillation following a failed AF ablation, Study contact information Professor Claire Hogg. Study contact information Name:Natalie Dormand (Royal Brompton), Paula Rogers (Harefield)Email:N.Dormand@rbht.nhs.uk, p.rogers@rbht.nhs.uk, Study Examining the role of mitochondrial oxidative stress in dilated cardiomyopathy, Study contact information A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF), Study A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of INS1007 Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis INS1007-301, Principal investigator Name:Matthew JohnsonEmail:M.Johnson@rbht.nhs.uk, Study Name: Sally MeahEmail: S.Meah@rbht.nhs.uk, Study contact information Study Name: Dr Chiara Bucciarelli-DucchiEmail: c.bucciarelli-ducci@rbht.nhs.uk, Principal investigator Office 707 S Garfield Ave Ste 101 Alhambra, CA 91801 Phone+1 626-282-1600 Fax+1 626-656-1261 Is this information wrong? Benjamin Garfield 1 , Charles McFadyen 2 , Charlotte Briar 2 , Caroline Bleakley 2 , Aikaterini Vlachou 2 , Melissa Baldwin 2 , Nick Lees 3 , Susanna . Name:Dr Karthikan SrikanthanEmail:K.Srikanthan@rbht.nhs.uk, Study Name:Professor Martin CowieEmail:m.cowie@rbht.nhs.uk, Study Name: Maria NunezEmail: m.nunez@rbht.nhs.uk, Study Name: Mr Philip MolyneauxEmail: p.molyneaux@rbht.nhs.uk, Principal investigator Dr Rosemary Boyton, Study MrAndreas Hoschtitzky. Diagnosis and risk stratification in myocarditis using cardiovascular magnetic resonance, detailed molecular markers and gene sequencing - a personalised approach. The MISTER trial is looking at testing whether minimal equipment pulmonary rehabilitation classes are as effective as those that use specialist equipment in terms of the effect on fitness levels, breathlessness and quality of life in the short and medium term. Improving outcome measures for physiotherapy trials of airway clearance in adults with CF, Study contact information Relationship between patient phenotypes and exacerbations in chronic obstructive pulmonary disease, Study contact information Name:Peng ZhangEmail:p.zhang@rbht.nhs.uk, Study A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation. Professor Fan Chung, Study Perspectives On Screening and early Treatment for Pulmonary Fibrosis: a qualitative study, Study contact informationName: Dr Elizabeth RenzoniEmail: e.renzoni@rbht.nhs.uk. Analysis of electrograms in cardiac arrhythmia to aid diagnosis and patient stratification, Study contact information UK lung volume reduction - multicentre observational, Study contact information Professor Jadwiga Wedzicha, Study Incidence and Pathogenesis of Invasive Aspergillosis in Intensive Care Patients with Severe Influenza (AspiFLu), Study contact information A double-blind, placebo controlled, multicentre, clinical trial to investigate the efficacy and safety of 12 months of therapy with inhaled Promixin (colistimethate sodium) in the treatment of subjects with non-cystic fibrosis bronchiectasis, Study National Study of prenatally diagnosed right aortic arch and double arch: Incidence; associations and outcomes. Inhalation challenge to assess Inducible Laryngeal Obstruction CHILO. Name: Nikula VicarioEmail: n.vicario@rbht.nhs.uk, Study Study Name: Dr Teresa LeeEmail: t.lee@rbht.nhs.uk. Biomarker- guided intervention to prevent acute kidney injury after major non-cardiac surgery - the prospective multicenter randomized controlled interventional trial, Study contact informationName: Alessandra VerzelloniEmail: a.verzellonisef@rbht.nhs.uk. Study Many experts have expertise treating . Sample collection study to explore CIrCulating tumour cells, cell free DNA and leucocytes with ImagesTReam analysis in patients with various cancers, Study contact informationName: Paula RogersEmail: p.rogers@rbht.nhs.uk. A phase 1, open-label, single-dose, non-randomised study to evaluate pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients, Study contact information University of Cambridge NHS health data consent survey. Name:Dr Siobhan CarrEmail:s.carr@rbht.nhs.uk, Study Retrospective review of lung function data in a tertiary paediatric respiratory cohort, Study contact information Name:Dr Janice TillEmail:j.till@rbht.nhs.uk, Study Study contact informationName: Dr Elizabeth RenzoniEmail: E.Renzoni@rbht.nhs.uk, Principal investigator A 2x2 factorial randomised single blind open labelled trial to determine the clinical and cost -effectiveness of hypertonic saline (HTS 6%) and carbocysteine versus usual care over 12 months in non-cystic fibrosis bronchiectasis (BE): The Clear study, Study Principal investigator The study, the largest of its kind worldwide, was led at by Dr Laura Price, consultant physician for pulmonary hypertension, and by Dr Benjamin Garfield, consultant in critical care. He also had the brilliant and revolutionary idea of integrating medical schools with hospitals, to ensure people would be treated effectively now and in future. Quadriceps neuromuscular electrical stimultaion (NMES) as an adjunct to pulmonary rehabilitation in patients with COPD and quadriceps weakness - a randomised double-blind placebo-controlled trial. Dr Stephen John Wort, Study The measurement of transmural myocardial perfusion in normal subjects and patients with hypertension, hypertrophic cardiomyopathy (HCM) and HCM phenocopies with Cardiovascular Magnetic Resonance (CMR), Study contact information Professor Martin Cowie, Study A randomised, double-blind, placebo-controlled study, in COPD patients with and without a confirmed respiratory virus infection assessing anti-viral biomarker responses of inhaled SNG001 compared to placebo. Advanced Search. Study Study contact information DARS-NIC-144568-D7G6V, Study contact informationName:Amrit LotaEmail:A.Lota@rbht.nhs.uk. Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading, Study contact informationName: Laura BarkerEmail: l.barker2@rbht.nhs.uk, Study A Phase 3, 2-Arm, open-label study to evaluate the safety and pharmacodynamics of long-term Ivacaftor treatment in subjects with Cystic Fibrosis who are less than 24 Months of age at treatment initiation and have a CFTR gating mutation, Study contact information We anaesthetise patients with severe pulmonary hypertension for various surgical and non-surgical procedures, both cardiac and non-cardiac. Assessing mitochondrial bioenergetics in coronary heart disease; correlating cardiac magnetic resonance with the molecular processes that underpin myocardial dysfunction and left ventricular reverse remodelling. Nasal High-Flow Oxygen Therapy After Cardiac Surgery (NOTACS) Study: Effect of High-Flow Nasal Therapy on Patient-Centred Outcomes in Patients at High Risk of Postoperative Pulmonary Complications After Cardiac Surgery: A Multicentre Randomised Controlled Trial. Real-world experience of dupilumab for the treatment of severe asthma in the United Kingdom: a retrospective study. Name:DrIlariaCazzoliEmail:I.Cazzoli@rbht.nhs.uk. Professor Paul Cullinan. A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF), Study contact information Professor Dudley Pennell. Coagulation markers on discarded plasma samples from patients with severe COVID-19, Study contact information Study contact informationName: Melissa RochonEmail: m.rochon@rbht.nhs.uk, Principal investigator Study contact informationName: Professor Eric LimEmail: E.Lim@rbht.nhs.uk, Principal investigator Name: Jessie MatthewsEmail: J.Matthews@rbht.nhs.uk. Name:Professor Toby MaherEmail:T.Maher@rbht.nhs.uk, Study A Pan-European Multi-Centre Observational Study To Determine The Natural History Of Patients With Alpha-1 Antitrypsin Deficiency And The Impact Of Augmentation Therapy, Study contact information We provide private. Name:Professor Susanna PriceEmail: s.price@rbht.nhs.uk, Principal investigator The Clinical and psychosocial impact of COVID-19 on patients with neuromuscular and neurological disorders, Study contact information Dr. Benjamin C. Tam is certified by American Board of Orthopaedic Surgery. NEw Understanding of the tReatment Of COUGH (NEUROCOUGH) European Chronic Cough Registry and Bio-Resource Protocol. 4D Motion of the aorta in the chest and simulated wall stress distribution in relation to aortic events, Study contact information Royal Brompton Hospital Contact: 020 7352 8121 ext 84133/ rbh-tr.thoraciccns-rbh@nhs.net Harefield Hospital Contact: 01895 828989/ rbh-tr.harefieldlungcns@nhs.net Administrative team Royal Brompton Hospital cancer team Maura Gallagher, cancer MDT co-ordinator Contact: 020 7352 8121 (ext 4303) Harefield Hospital cancer team Professor Simon Padley, Study An open-label study to assess the safety, pharmacokinetics and pharmacodynamics of inhaled PC945 in adult Cystic Fibrosis (CF) patients with persistent pulmonary Aspergillus fumigatus infection, Study contact information Name: Dr Francesca ConwayEmail:f.conway@rbht.nhs.uk, Study Randomised, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia, Study contact information Name: Dr Joyce WongEmail: J.Wong@rbht.nhs.uk, Study Real World Study of the Tendyne Mitral Valve System to Treat Mitral Regurgitation (Tendyne PMCF Study), Principal investigator Genetics of susceptibility and mortality in critical care (GenOMICC), Study contact information See details of ourperformance for all clinical trials reported to the NIHR, for the Initiation and Delivery of studies in the period from 1 October 2020 to 31 March 2021. Assessment and validation of a device for measuring hydrogen peroxide in exhaled breath condensate in Healthy Volunteers, Study contact information Principal investigator Study contact information Study An evaluation of the benefits of a single dose of Simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients, Study contact information Safety and performance evaluation of the AccuCinch Ventricular Repair System for the treatment of heart failure with or without Functional Mitral Regurgitation due to Dilated Ischaemic or Non-Ischaemic Cardiomyopathy. Name:Cai SimEmail:c.sim@rbht.nhs.uk, Principal investigator 2021 Guy's and St Thomas' NHS Foundation Trust, ourperformance for all clinical trials reported to the NIHR, Chronic Obstructive Pulmonary Disease (COPD), Epidemiology and Prognosis in Acute Myocarditis, Health Research Authority (HRA) and ethics approval, Patient and public involvement for researchers, How patients and the public can get involved. National Validation and Sensitivity to Change of a scale to measure quality of life in patients with severe asthma. 7Department of Cardiology, Royal Brompton Hospital, Sydney Street, London, UK; Department of Echocardiography, Royal Brompton Hospital, Sydney Street, London, UK. Name: Kamal LiyanageEmail: k.liyanage@rbht.nhs.uk, Principal investigator Name:Debra DempsterEmail:D.Dempster@rbht.nhs.uk, Study Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study, Study contact information Assessing Organisational Readiness for Heart Failure Remote Monitoring, Study contact information Name:Maria NunezEmail: M.Nunez@rbht.nhs.uk, Principal investigator A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease with Chronic Bronchitis, Study contact information Improving Assessment of Diagnosis and Prognosis in Cardiac Sarcoidosis, Study contact informationName:Dr Alessia AzzuEmail:A.Azzu@rbht.nhs.uk, Study Name:Dr Nicholas SimmondsEmail:N.Simmonds@rbht.nhs.uk. Name:Dexter WisemanEmail:D.Wiseman@rbht.nhs.uk, Principal investigator Real World Clinical Outcomes With Novel Modifier Therapy Combinations in People with CF, Study contact information Name:Ahmad SadakaEmail:A.Sadaka@rbht.nhs.uk, Study Study Clinical Outcomes With Novel Modifier Therapy Combinations in CF, Study Tous les types; Assurance; Dentiste Prospective Study of Cellular & Clinical Aspects of Moderate to Severe Asthma, Study contact information 2 Division of Anaesthetics, Pain Medicine, and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, United Kingdom. 21+. Professor Michael Polkey, Study Professor Jane Davies. Name:Claire NolanEmail:c.nolan@rbht.nhs.uk. Name:Dr Benjamin GarfieldEmail:B.Garfield@rbht.nhs.uk, Study A Phase 3b Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects Ages 6 Years and Older Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)", Study contact information A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes), Study Genetic determinants of Kawasaki disease for susceptibility and outcome, Study contact information A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a)Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD), Study contact information New patients are welcome. Study Severe wheeze and asthma validation study, Study contact information Professor Andrew Menzies-Gow, Study Study Study Professor Mahmoud Barbir. INHALE: Personal pollution exposure and effects on the lungs in healthy and asthmatic individuals, Principal investigator Study contact information Dr VasileiosPanoulas. Study Name:Olga ArchangelidiEmail:o.archangelidi@rbht.nhs.uk, Study Your destination for buying luxury property in Voiron, Auvergne-Rhne-Alpes, France. Dr Ciara Bucciarelli-Ducchi, Study PAciFy Cough: A multicentre, double blind, placebo controlled, crossover trial of morphine sulfate for the treatment of PulmonAry Fibrosis Cough, Study contact informationName:Zhe WuEmail:Z.Wu@rbht.nhs.uk.

Smartview2 System Menu Pin, Articles D